Abstract:A series of new quinoline derivatives was designed, synthesized and evaluated as potential antitumor agents. The results indicated that most compounds exhibited potent antiproliferative activity, and 7-(4-fluorobenzyloxy)N-(2-(dimethylamino)- ethyl)quinolin-4-amine 10g was found to be the most potent antiproliferative agent against human tumor cell lines with an IC50 value of less than 1.0 μM. Preliminary structure-activity relationships analysis suggested that (1) the large and bulky alkoxy substituent in position-7 might be a beneficial pharmacophoric group for antiproliferative activity; (2) the amino side chain substituents in position-4 facilitated the antiproliferative activity of this class of compounds; and (3) the length of the alkylamino side chain moiety affected the antiproliferative potency, with two CH2 units being the most favorable. Further investigation of the mechanism of action of this class of compounds demonstrated that the representative compound 10g triggered p53/Bax-dependent colorectal cancer cell apoptosis by activating p53 transcriptional activity. Moreover, the results showed that compound 10g effectively inhibited tumor growth in a colorectal cancer xenograft model in nude mice. Thus, these quinoline derivatives might serve as candidates for the development of new antitumor drugs.

Synthesis and Anti-Tumor Activities of Five Novel 4-Arylamino-6-bromoquinazolines

Synthesis and bioactivity of 4-arylamino-6,7-dimethoxyl quinazoline derivatives

Synthesis and Antitumor Activity of Novel 4-Aminoquinazoline Derivatives Containing Benzothiazole

The synthesis and anti-tumor activity research of a novel quinazoline derivatives

Synthesis of 4-substituted-7-chloroquinoline derivatives and preliminary evaluation of their antitumor activity

Synthesis and Anti-tumor Activity in Vitro of 5 Kinds of New Tetrahydroquinoline Derivatives

Synthesis and Evaluation of 4(3H) -Quinazolinone Derivatives Bearing Aromatic Amine Side Chains As Antitumor Agents

Design, synthesis and anti-tumor activity evaluation of 4,6,7-substitute quinazoline derivatives

Synthesis and Bioactivities of 6,7,8-Trimethoxy-n-aryl-4-aminoquinazoline Derivatives

Synthesis, in Vitro and in Vivo Evaluation of Novel Substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines As Potent Antitumor Agents.

Synthesis and antitumor activity evaluation in vitro of 4-aminoquinazoline derivatives containing 1,3,4-thiadiazole

Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.

Synthesis and Antitumor Activity of 2,4,6-Trisubstituted Novel Quinazoline Derivatives Containing Trifluoromethyl

Synthesis of Novel Quinazolin-4-One Derivatives Bearing Benzo[C]-Chromen-6-One and Their Anti-Tumor and Antimicrobial Activities

Synthesis and Biological Evaluation of Novel Substituted 4‐anilinoquinazolines As Antitumor Agents

Design, Synthesis, Structure-Activity Relationships and Mechanism of Action of New Quinoline Derivatives As Potential Antitumor Agents

2,3-Disubstituted 8-Arylamino-3h-imidazo[4,5-g]quinazolines: A Novel Class of Antitumor Agents

Synthesis Andin Vitroantitumor Activities of 6,7-Dimethoxy-4-piperazinquinazoline Thiosemicarbazone Derivatives

Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells

Synthesis, cytotoxic and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety.

Synthesis and Antitumor Activity of Heterozygous Isatin-Quinazoline Compounds